Abstract:Chronic arsenic exposure is a global health hazard significantly associated with the development of deleterious cutaneous changes and increased keratinocyte cancer risk. Although arsenic exposure is associated with broad-scale cellular and molecular changes, gaps exist in understanding how these changes impact the skin and facilitate malignant transformation. Recently developed epigenetic "clocks" can accurately predict chronological, biological and mitotic age, as well as telomere length, on the basis of tissue DNA methylation state. Deviations of predicted from expected age (epigenetic age dysregulation) have been associated with numerous complex diseases, increased all-cause mortality and higher cancer risk. We investigated the ability of these algorithms to detect molecular changes associated with chronic arsenic exposure in the context of associated skin lesions. To accomplish this, we utilized a multi-algorithmic approach incorporating seven "clocks" ( Horvath, Skin&Blood, PhenoAge, PCPhenoAge, GrimAge, DNAmTL and epiTOC2 ) to analyze peripheral blood of pediatric and adult cohorts of arsenic-exposed (n = 84) and arsenic-naïve (n = 33) individuals, among whom n = 18 were affected by skin lesions. Arsenic-exposed adults with skin lesions exhibited accelerated epigenetic ( Skin&Blood : + 7.0 years [95% CI 3.7; 10.2], q = 6.8 × 10 –4 ), biological ( PhenoAge: + 5.8 years [95% CI 0.7; 11.0], q = 7.4 × 10 –2 , p = 2.8 × 10 –2 ) and mitotic age ( epiTOC2: + 19.7 annual cell divisions [95% CI 1.8; 37.7], q = 7.4 × 10 –2 , p = 3.2 × 10 –2 ) compared to healthy arsenic-naïve individuals; and accelerated epigenetic age ( Skin&Blood: + 2.8 years [95% CI 0.2; 5.3], q = 2.4 × 10 –1 , p = 3.4 × 10 –2 ) compared to lesion-free arsenic-exposed individuals. Moreover, lesion-free exposed adults exhibited accelerated Skin&Blood age (+ 4.2 [95% CI 1.3; 7.1], q = 3.8 × 10 –2 ) compared to their arsenic-naïve counterparts. Compared to the pediatric group, arsenic-exposed adults exhibited accelerated epigenetic (+ 3.1 to 4.4 years (95% CI 1.2; 6.4], q = 2.4 × 10 –4 –3.1 × 10 –3 ), biological (+ 7.4 to 7.8 years [95% CI 3.0; 12.1] q = 1.6 × 10 –3 –2.8 × 10 –3 ) and mitotic age (+ 50.0 annual cell divisions [95% CI 15.6; 84.5], q = 7.8 × 10 –3 ), as well as shortened telomere length (− 0.23 kilobases [95% CI − 0.13; − 0.33], q = 2.4 × 10 –4 ), across all seven algorithms. We demonstrate that lifetime arsenic exposure and presence of arsenic-associated skin lesions are associated with accelerated epigenetic, biological and mitotic age, and shortened telomere length, reflecting altered immune signaling and genomic regulation. Our findings highlight the usefulness of DNA methylation-based algorithms in identifying deleterious molecular changes associated with chronic exposure to the heavy metal, serving as potential prognosticators of arsenic-induced cutaneous malignancy.

SILAC-based quantitative proteomic analysis reveals widespread molecular alterations in human skin keratinocytes upon chronic arsenic exposure

Dynamic alteration in miRNA and mRNA expression profiles at different stages of chronic arsenic exposure-induced carcinogenesis in a human cell culture model of skin cancer

SILAC-Based Quantitative Proteomic Analysis Unveils Arsenite-Induced Perturbation of Multiple Pathways in Human Skin Fibroblast Cells

Aberrantly Expressed Genes in HaCaT Keratinocytes Chronically Exposed to Arsenic Trioxide

Proteomic Profiling Reveals Candidate Markers for Arsenic-Induced Skin Keratosis.

Signatures of epigenetic, biological and mitotic age acceleration and telomere shortening are associated with arsenic-induced skin lesions

Aberrant Methylation of Nucleotide Excision Repair Genes is Associated with Chronic Arsenic Poisoning

miRNA expression profiles of premalignant and malignant arsenic-induced skin lesions

Arsenic Induces P62 Expression to Form a Positive Feedback Loop with Nrf2 in Human Epidermal Keratinocytes: Implications for Preventing Arsenic-Induced Skin Cancer

Long term exposure to low doses of sodium arsenite on effect of apoptosis in immortalized human skin cutin forming cells

Screening the critical protein subnetwork to delineate potential mechanisms and protective agents associated with arsenic-induced cutaneous squamous cell carcinoma: A toxicogenomic study

Characterization of Response to Acute and Chronic Arsenic Toxicity in CD34high-enriched Epidermal Stem Cells

Clonal variability in chromosomal instability as a potential driver in the acquisition of tumorigenic phenotype in chronic arsenic-exposed and hsa-miR-186 overexpressing human keratinocytes

Integration of microRNAome, proteomics and metabolomics to analyze arsenic-induced malignant cell transformation.

Association of H3K79 monomethylation (an epigenetic signature) with arsenic-induced skin lesions

Dose Response Evaluation of Gene Expression Profiles in the Skin of K6/ODC Mice Exposed to Sodium Arsenite

Chronic Low Dose Arsenic Exposure Preferentially Perturbs Mitotic Phase of the Cell Cycle

Association of Methionine Synthase Rs1805087 Polymorphism with Arsenic-Related Skin Pigmentary Changes: A Population-Based Case-Control Study

Low Selenium Status Affects Arsenic Metabolites in an Arsenic Exposed Population with Skin Lesions.

Arsenic Induced Overexpression of Inflammatory Cytokines Based on the Human Urothelial Cell Model in Vitro and Urinary Secretion of Individuals Chronically Exposed to Arsenic

Interplay Between Cellular Methyl Metabolism and Adaptive Efflux During Oncogenic Transformation from Chronic Arsenic Exposure in Human Cells